Description
Product details
DAPA VILDA 10/100 SR Dapagliflozin (10mg), Vildagliptin SR (100mg) Introduction to DAPA VILDA 10/100 SR DAPA VILDA 10/100 SR is a combination medication that includes Dapagliflozin 10mg and Vildagliptin 100mg in a sustained-release (SR) formulation. This medication is primarily used for the management of type 2 diabetes mellitus. Dapagliflozin and Vildagliptin work together to improve blood sugar control through complementary mechanisms, making this combination an effective treatment option for patients needing comprehensive glycemic management. What are Dapagliflozin and Vildagliptin? Overview of Dapagliflozin Dapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood. Instead, it allows glucose to be excreted in the urine, thereby lowering blood glucose levels. Overview of Vildagliptin Vildagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances the body's natural incretin hormones, which help regulate blood glucose by increasing insulin release and decreasing glucagon levels in response to meals. The sustained-release formulation ensures a prolonged effect throughout the day. Benefits of DAPA VILDA 10/100 SR Effective Blood Sugar Management Postprandial and Fasting Glucose Control: Vildagliptin helps regulate postprandial (after-meal) glucose levels, while Dapagliflozin assists in lowering fasting glucose levels by promoting glucose excretion through urine. Comprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management. Weight Management and Cardiovascular Benefits Weight Reduction: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine. Cardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients. Convenience and Compliance Once-Daily Dosing: The sustained-release formulation of Vildagliptin allows for once-daily dosing, improving patient compliance and convenience. Reduced Pill Burden: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy. How to Use DAPA VILDA 10/100 SR Dosage and Administration Recommended Dosage: The typical dosage of DAPA VILDA 10/100 SR is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels. Administration: Take the tablet with or without food, preferably at the same time each day to maintain consistent blood levels of the medication. Swallow the tablet whole with a full glass of water. Guidelines for Optimal Use Consistent Use: For best results, take DAPA VILDA 10/100 SR regularly as prescribed by your healthcare provider. Monitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 Order Now https://www.sterisonline.com/product/dapa-vilda-10-100-sr-134064